Citation Impact
Citing Papers
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
2003 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Probucol Increases Glutathione Peroxidase-1 Activity and Displays Long-Lasting Protection against Methylmercury Toxicity in Cerebellar Granule Cells
2009
Toxicological and pathophysiological roles of reactive oxygen and nitrogen species
2010
Traditional Chinese Medicine for Cardiovascular Disease
2017 Standout
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
2012 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis
2007
Relocalization of Cathepsin D and Cytochrome c Early in Apoptosis Revealed by Immunoelectron Microscopy
2001
Pathological roles of MAPK signaling pathways in human diseases
2010 Standout
Advances in metal-induced oxidative stress and human disease
2011 Standout
Calcium, ATP, and ROS: a mitochondrial love-hate triangle
2004 Standout
Doxorubicin Cardiotoxicity and the Control of Iron Metabolism: Quinone-Dependent and Independent Mechanisms
2004
STRESS signaling pathways that modulate cardiac myocyte apoptosis
2004
Mitochondrial creatine kinase in human health and disease
2005
Mitochondrial Ca<sup>2+</sup> Signaling and Cardiac Apoptosis
2001
Biodegradable luminescent porous silicon nanoparticles for in vivo applications
2009 Standout
Metallothioneins, oxidative stress and the cardiovascular system
2000
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations
2011 Standout
A compendium of proteins that interact with HIF-1α
2017 StandoutNobel
Just the Beginning: Novel Functions for Angiotensin-Converting Enzymes
2002
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Status of myocardial antioxidants in ischemia–reperfusion injury
2000
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
2002 Standout
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Role of oxidative stress in cardiovascular diseases
2000
Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategies
2005
Effects of fructose-1,6-diphosphate on concentration of calcium and activities of sarcoplosnic Ca2+-ATPase in cardiomyocytes of Adriamycin-treated rats
2005
Mitochondria as a Pharmacological Target
2002
The inflammatory response in myocardial infarction
2002 Standout
Four deaths and a funeral: from caspases to alternative mechanisms
2001 Standout
Oxidant-Induced Iron Signaling in Doxorubicin-Mediated Apoptosis
2004
Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Adriamycin-Induced Cardiomyopathy in Hamsters
2002
Activation of Poly(ADP-Ribose) Polymerase Contributes to Development of Doxorubicin-Induced Heart Failure
2002
Protecting the myocardium: A role for the β2 adrenergic receptor in the heart
2004 StandoutNobel
Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
2012
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Potentiation of Doxorubicin Cardiotoxicity by Iron Loading in a Rodent Model
2007
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Myocarditis
2000 Standout
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Reactive oxygen species in cardiovascular disease
2011
In vitro and in vivo antitumor effects of doxorubicin loaded with bacterial magnetosomes (DBMs) on H22 cells: The magnetic bio-nanoparticles as drug carriers
2007
Potential protective role of angiotensin‐converting enzyme inhibitors captopril and enalapril against adriamycin‐induced acute cardiac and hepatic toxicity in rats
2001
Structure and function of “metalloantibiotics”
2003
Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study
2012
Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease
1999
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
2007 Standout
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Preservation of Fertility in Patients with Cancer
2009 Standout
Human genetics, animal models and computer simulations for studying hypertension☆
2004 StandoutNobel
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Signals of Oxidant-Induced Cardiomyocyte Hypertrophy: Key Activation of p70 S6 Kinase-1 and Phosphoinositide 3-Kinase
2002
Cardiotoxicity of cytotoxic drugs
2003
Reactive Oxygen Species-Induced Activation of the MAP Kinase Signaling Pathways
2006
Rnd3/RhoE Modulates Hypoxia-Inducible Factor 1α/Vascular Endothelial Growth Factor Signaling by Stabilizing Hypoxia-Inducible Factor 1α and Regulates Responsive Cardiac Angiogenesis
2016
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
1995 Standout
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience
2002 Standout
L‐carnitine prevents doxorubicin‐induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation
1999
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
2004 Standout
Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants
2015 Standout
Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
2004 Standout
Diminished molecular response to doxorubicin and loss of cardioprotective effect of dexrazoxane inEgr-1deficient female mice
2001
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Potent Metalloporphyrin Peroxynitrite Decomposition Catalyst Protects Against the Development of Doxorubicin-Induced Cardiac Dysfunction
2003
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Cellular and Molecular Dissection of Reperfusion Injury
2000 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Global burden of heart failure: a comprehensive and updated review of epidemiology
2022 Standout
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
2006 Standout
Works of Timao Li being referenced
Apoptosis in Adriamycin Cardiomyopathy and Its Modulation by Probucol
2001
Early changes in myocardial antioxidant enzymes in rats treated with adriamycin
2002
Chronic Treatment with Propranolol Induces Antioxidant Changes and Protects Against Ischemia–Reperfusion Injury
1997
Adriamycin-induced heart failure: mechanisms and modulation
2000
Rnd3 haploinsufficient mice are predisposed to hemodynamic stress and develop apoptotic cardiomyopathy with heart failure
2014
Modulation of adriamycin-induced changes in serum free fatty acids, albumin and cardiac oxidative stress
1998
Apoptosis in Isolated Adult Cardiomyocytes Exposed to Adriamycina
1999
Mechanisms of beneficial effects of probucol in adriamycin cardiomyopathy
1999
Adriamycin-Induced Early Changes in Myocardial Antioxidant Enzymes and Their Modulation by Probucol
2000
Adriamycin cardiomyopathy: pathophysiology and prevention
1997
Early changes in myocardial antioxidant enzymes in rats treated with adriamycin
2001
Modulation of adriamycin-induced changes in serum free fatty acids, albumin and cardiac oxidative stress
1998
Mechanisms of beneficial effects of probucol in adriamycin cardiomyopathy
1999